[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368729-105":59,"doc-detail-368729-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","stroma-areactive-invasion-front-areas-sarifa-in-1298-pt3pt4-colorectal-cancers-a-strong-prognostic-parameter-complementing-established-morphological-criteria","Stroma Areactive Invasion Front Areas (SARIFA) in 1,298 pT3/pT4 Colorectal Cancers - A strong prognostic parameter complementing established morphological criteria","","Stroma Areactive Invasion Front Areas (SARIFA) was evaluated as a prognostic parameter in 1,298 patients with pT3/pT4 colorectal cancer. The study assessed direct proximity between cancer cells and adipocytes in a multicentre cohort and analyzed its relationship with established histopathology parameters, including tumour budding, grade, and subtypes. SARIFA showed adverse clinicopathological associations and significantly worse outcomes across disease-specific survival and other metrics, including multiple pTNM stages and stratified subgroups, remaining significant in multivariable hazard ratio models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stroma-areactive-invasion-front-areas-sarifa-in-1298-pt3pt4-colorectal-cancers-a-strong-prognostic-parameter-complementing-established-morphological-criteria/368729/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stroma-areactive-invasion-front-areas-sarifa-in-1298-pt3pt4-colorectal-cancers-a-strong-prognostic-parameter-complementing-established-morphological-criteria/368729.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SARIFA and how is it assessed in this study?","Question",{"text":112,"@type":113},"SARIFA refers to the presence of Stroma Areactive Invasion Front Areas, defined by the direct proximity between cancer cells and adipocytes. It is assessed in a multicentre cohort of 1,298 patients with pT3/pT4 colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SARIFA affect prognosis in pT3/pT4 colorectal cancers?",{"text":117,"@type":113},"SARIFA is associated with adverse clinicopathological features and indicates poor prognosis. It remains significant across survival metrics, including disease-specific survival, and across pTNM stages.",{"name":119,"@type":110,"acceptedAnswer":120},"Does SARIFA add prognostic information beyond established histopathological criteria?",{"text":121,"@type":113},"Yes. The study shows SARIFA identifies additional adverse prognostic subgroups within tumour budding and grade categories, and within histopathological subtypes. Multivariable analyses confirm SARIFA remains a significant prognostic factor alongside pTNM stage and other parameters.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368729,1790498781,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Histopathology 2025, 87, 464–473. DOI: 10.1111/his.15501  \nStroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria  \nSebastian Foersch, 1 Nuwar Harb,2 Anne-Sophie Litmeyer,2 Wilfried Roth, 1 Irina Breus,2 Johannes Schraml,2 Annika Weiß,2 Katja Steiger, 3  \nJulia Teply-Szymanski,2 Detlef K Bartsch,4 Carsten Denkert,2 Maxime Schmitt2 & Moritz Jesinghaus2  \n1Institute of Pathology, University Medical Center, Mainz, 2Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, Marburg, 3Institute of Pathology, Technical University of Munich, Munich and 4Department of Surgery, Philipps-University Marburg and University Hospital Marburg, Marburg, Germany  \nDate of submission 10 March 2025 Accepted for publication 7 June 2025  \nFoersch S, Harb N, Litmeyer A-S, Roth W, Breus I, Schraml J, Weiß A, Steiger K, Teply-Szymanski J,  \nBartsch D K, Denkert C, Schmitt M & Jesinghaus M  \n(2025) Histopathology 87, 464–473. [https://doi.org/10.1111/his.15501](https://doi.org/10.1111/his.15501)  \nStroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria  \nAims: Colorectal carcinoma (CRC) is one of the most common cancers worldwide and is associated with signiﬁcant morbidity and mortality. Histopathology plays a crucial role in the diagnosis, prognostication and treatment planning of CRC. In addition to well-established morphological parameters such as tumour budding, grade and histopathological subtypes, the interaction between tumour cells and adipose tissue has gained increasing attention.  \nMethods and results: The frequency of direct proximity between cancer cells and adipocytes, termed Stroma Areactive Invasion Front Areas (SARIFA), was assessed in a multicentre cohort of 1,298 patients with pT3/ pT4 CRC. The prognostic impact of SARIFA was evaluated, with a particular focus on its relationship with established histopathological parameters. SARIFA was associated with adverse clinicopathological features and served as an indicator of poor prognosis across all  \nsurvival metrics in the overall cohort (disease-speciﬁc survival [DSS]; P \u003C 0.001) . This prognostic value remained signiﬁcant across all pTNM stages (e.g. DSSin pT3, pN0, pN1/2, pM0 CRC; P \u003C 0.001, respectively) and identiﬁed additional adverse prognostic subgroups within tumour budding and grade categories (DSS, P \u003C 0.001, respectively) and within histopathological subtypes. In multivariable analyses, including pTNM stage and the aforementioned histopathological parameters, SARIFA remained a highly signiﬁcant prognostic factor (DSS P \u003C 0.001, hazard ratio: 1.73) . Discussion: Our study conﬁrms the high prognostic relevance of SARIFA across key clinicopathological subgroups of CRC and highlights its value as a meaningful complement to established morphological parameters. Given its ability to provide additional prognostic insights, our ﬁndings advocate for its inclusion in pathology reports to improve risk assessment and clinical management.  \nAddress for correspondence: M. Jesinghaus, Institute of Pathology, University Hospital Marburg, Baldingerstraße, 35043 Marburg, Germany.  \n[e-mail:](e-mail: moritz.jesinghaus@uni-marburg.de)[ moritz.jesinghaus@uni-marburg.de](e-mail: moritz.jesinghaus@uni-marburg.de)  \nAbbreviations: Bd, tumour budding; CRC, colorectal carcinoma; DFS, disease-free survival; DSS, disease-speciﬁc survival; HE, Haematoxylin and Eosin; HR, hazard ratio; OS, overall survival; SARIFA, Stroma Areactive Invasion Front Areas; UICC, Union for International Cancer Control; WHO, World Health Organization.  \n􀀁 2025 The Author(s) . Histopathology published by John Wiley & Sons Ltd.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided","cbCaiix0hXvK0bZt","https://ap.wps.com/l/cbCaiix0hXvK0bZt","pdf",1864103,"English","# Aims\n# Methods and results\n## Prognostic impact across survival metrics and pTNM stages\n# Discussion\n# Introduction\n## Existing prognostic framework and need for additional parameters\n## WHO morphological criteria and established factors","[{\"question\":\"What is SARIFA and how is it assessed in this study?\",\"answer\":\"SARIFA refers to the presence of Stroma Areactive Invasion Front Areas, defined by the direct proximity between cancer cells and adipocytes. It is assessed in a multicentre cohort of 1,298 patients with pT3/pT4 colorectal cancer.\"},{\"question\":\"How does SARIFA affect prognosis in pT3/pT4 colorectal cancers?\",\"answer\":\"SARIFA is associated with adverse clinicopathological features and indicates poor prognosis. It remains significant across survival metrics, including disease-specific survival, and across pTNM stages.\"},{\"question\":\"Does SARIFA add prognostic information beyond established histopathological criteria?\",\"answer\":\"Yes. The study shows SARIFA identifies additional adverse prognostic subgroups within tumour budding and grade categories, and within histopathological subtypes. Multivariable analyses confirm SARIFA remains a significant prognostic factor alongside pTNM stage and other parameters.\"}]","Stroma Areactive Invasion Front Areas (SARIFA) in 1,298 pT3/pT4 Colorectal Cancers - A strong prognostic parameter complementing established morphological criteria | PDF",1790178234,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77b715475db3b7e8cbebb7804d27a2ca.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/344a9236110acdbed5a96776934f4178.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/580e3ad48ffa470bf6077f255541c00e.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0f9b366003606aa675227bf02447561.webp",980,1287]